CompoAtlas

Arkogélules Bronches Poumons

Food supplement declared in France, decision dated 2 February 2026

Arkogélules Bronches Poumons (Arkopharma) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Eucalyptus globulus 60 mg per day, Cinnamomum camphora 30 mg per day, Myrtus communis 30 mg per day, Thymus vulgaris 30 mg per day, Lavandula latifolia 18 mg per day. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Arkopharma
Food business operator placing the product on the market
LABORATOIRES ARKOPHARMA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
3 capsules
Directions for use
1 capsule matin, midi et soir au moment des repas avec un grand verre d’eau, pendant 5 jours.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Ulcer (stomach or duodenum), Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Respiratory tract, Immunity

Declaration 353447, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Eucalyptus globulus Labill.Essence (feuille)Distillation60 mg
Cinnamomum camphora (L.) J. PreslEssence (feuille)Distillation30 mg
Myrtus communis L.Essence (feuille)Distillation30 mg
Thymus vulgaris L.Essence (sommités fleuries)Distillation30 mg
Lavandula latifolia MedikEssence (sommités fleuries)Distillation18 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)

Additives

E407, E422, E1440

Other ingredients

huile de tournesol

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Ne pas utiliser pendant la grossesse et l’allaitement, chez les personnes ayant des antécédents de convulsion ou épileptiques, les personnes asthmatiques ou allergiques (huiles essentielles, eucalyptol, Lamiaceae) et en cas d’obstruction de troubles gastro-oesophagien et en cas d’ulcère ou d’inflammation du tractus digestif. Demandez conseil à un professionnel de santé en cas de prise d’immunosuppresseurs. Ne pas dépasser 2 semaines de prise.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Thymus vulgaris L.
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Arkopharma

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Arkogélules Bronches Poumons (Arkopharma): composition and regulation”, https://compoatlas.com/en/supplements/products/353447-arkogelules-bronches-poumons, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line